A Method for Assaying von Willebrand Factor (Ristocetin Cofactor)

Donald E Macfarlane; Jeanne Stibbe; Edward P Kirby; Marjorie B Zucker; Robert A Grant; Jean McPherson

doi:10.1055/s-0038-1651343

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1975; 34(01): 306-308
DOI: 10.1055/s-0038-1651343

Letter to the Editor

Schattauer GmbH

A Method for Assaying von Willebrand Factor (Ristocetin Cofactor)

Donald E Macfarlane

¹Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140

,

Jeanne Stibbe

¹Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140

,

Edward P Kirby

¹Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140

,

Marjorie B Zucker

²Department of Pathology, New York University, New York University Medical Center, New York, New York 10016

,

Robert A Grant

¹Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140

,

Jean McPherson

¹Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140

› Author Affiliations

Abstract

Full Text

References

References
1 Allain J. P, Cooper H. A, Wagner R. H, and Brinkhous K. M. 1975; Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. Journal of Laboratory and Clinical Medicine 85: 318.
2 Grant P. A, McPherson J, and Zucker M. B. 1975; Inhibition and reversal by ADP of human platelet aggregation induced by ristocetin or porcine von Willebrand factor. Federation Proceedings 34: 222.
3 Howard M. A, and Firkin B. G. 1971; Ristocetin - a new tool in the investigation of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 26: 362.
4 Kirby E. P, and Mills D. C. B. 1975 The interaction of bovine Factor VIII with human platelets. Journal of Clinical Investigation. In press.
5 Olson J. D, Brockway W. J, Fass D. N, Magnuson M. A, and Bowie E. J. W. 1975; Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation. American Journal of Clinical Pathology 63: 210.
6 Meyer D, Jenkins C. S. P, Dreyfus M. D, Fressinaud E, and Larrieu M.-J. 1974; Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity. British Journal of Haematology 28: 579.
7 Stibbe J, and Kirby E. P. 1975 a Inhibition of ristocetin-induced platelet aggregation by Haemaccel ® and fibrinogen. Abstract Vth International Congress of the International Society on Thrombosis and Haemostasis, Paris.
8 Stibbe J, and Kirby E. P. 1975 b Influence of fibrinogen, albumin and Haemaccel on ristocetin-induced platelet aggregation; its relevance to the quantitative measurement of the ristocetin cofactor. In preparation.
9 Weiss H. J, Hoyer L. W, Rickles F. R, Varma A, and Rogers J. 1973; Quantitative assay of plasma factor deficient in von Willebrand’s disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Journal of Clinical Investigation 52: 2708.
10 Zimmerman T. S, Ratnoff O. D, and Powell A. E. 1971; Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand’s disease. Journal of Clinical Investigation 50: 244.